FDA Inspection 980781 — Gulf Pharmaceutical Industries - Julphar
The FDA completed an inspection of Gulf Pharmaceutical Industries - Julphar on July 19, 2016 in Ras Al Khaimah. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- July 19, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ras Al Khaimah (United Arab Emirates)